US Patent Issued to JIANGSU KANION PHARMACEUTICAL on May 12 for "Multi-receptor (GLP-1 receptor, GIP receptor, and Gcg receptor) agonist protein" (Chinese Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,080, issued on May 12, was assigned to JIANGSU KANION PHARMACEUTICAL Co. LTD. (Lianyungang, China).

"Multi-receptor (GLP-1 receptor, GIP receptor, and Gcg receptor) agonist protein" was invented by Hai Chen (Nanjing, China), Gaoyong Liao (Nanjing, China) and Yi Zhang (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention provides a novel protein. Experimental results have shown that the protein has agonist activity at three receptors, namely the glucagon-like peptide 1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon (Gcg) receptor, and has both blood glucose lowering and body ...